COLL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Collegium Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 24.065 USD 1.54%

Market Cap: $780.4m

	Collegium Pharmaceutical Inc NASDAQ:COLL	US
	Microsoft Corp NASDAQ:MSFT	US
S	Seowonintech Co Ltd KOSDAQ:093920	KR

Profitability Summary

Collegium Pharmaceutical Inc's profitability score is 62/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

60%

Strong 3Y Average Gross Margin

59%

Gross Margin is Increasing

49% > 60%

Healthy Operating Margin

18%

Sustainable 3Y Average Operating Margin

25%

Declining Operating Margin

20% > 18%

Low Net Margin

Low 3Y Average Net Margin

Net Margin is Increasing

-2% > 6%

Exceptional Free Cash Flow Margin

41%

Strong 3Y Average Free Cash Flow Margin

40%

Declining Free Cash Flow Margin

44% > 41%

Positive ROE

18%

Exceptional 3Y Average ROE

View All

Hide

Collapse

62 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.